Houston Methodist

Showing 1 - 1 of 1 Cervical Cancer

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/?TroFuse-020/?GOG-3101/?ENGOT-cx20)

Status: Enrolling

Study Coordinator: Jaya Kamath

Phone: 713.441.6616

This study will have two phases: a sacituzumab tirumotecan safety run-in and a Phase 3 portion. The safety run-in phase will be used to evaluate the efficacy and safety of sacituzumab tirumotecan at the dose for evaluation in the Phase 3 portion. The... Read more >

Academic Events

Clinical Trials

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/?TroFuse-020/?GOG-3101/?ENGOT-cx20)